Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Corona

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
Environmental Toxicology and Pharmacology|September 8, 2024
Synergistic effects between microplastics and glyphosate on honey bee larvaeG A Mitton, M Corona, M Alburaki, et al.
The Journal of Surgical Research|April 16, 2026
Two for One? Safety and Efficacy of Concomitant Hernia Repair During Pediatric AppendectomyNicholas J Iglesias, Drew S Alessi, Akshat Sanan, et al.
Breast Cancer Research and Treatment|August 1, 2022
An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancerElgene Lim, Frances Boyle, Meena Okera, et al.
Journal of Esthetic and Restorative Dentistry : Official Publication of the American Academy of Esthetic Dentistry ... [Et Al.]|October 22, 2019
Influence of surface treatment on the fluorescence of composite resins subjected to in situ bleachingLourdes M G García, Ana Paula T de Godoi, Osvaldo A Serra, et al.
The Journal of Trauma and Acute Care Surgery|April 11, 2023
Burn excision within 48 hours portends better outcomes than standard management: A nationwide analysisWalter A Ramsey, Christopher F O'Neil, Andres M Corona, et al.
The Lancet. Oncology|May 1, 2020
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trialSara M Tolaney, Andrew M Wardley, Stefania Zambelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancerMartin R Stockler, Vernon J Harvey, Prudence A Francis, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
Environmental Toxicology and Pharmacology|September 8, 2024
Synergistic effects between microplastics and glyphosate on honey bee larvaeG A Mitton, M Corona, M Alburaki, et al.
The Journal of Surgical Research|April 16, 2026
Two for One? Safety and Efficacy of Concomitant Hernia Repair During Pediatric AppendectomyNicholas J Iglesias, Drew S Alessi, Akshat Sanan, et al.
Breast Cancer Research and Treatment|August 1, 2022
An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancerElgene Lim, Frances Boyle, Meena Okera, et al.
Journal of Esthetic and Restorative Dentistry : Official Publication of the American Academy of Esthetic Dentistry ... [Et Al.]|October 22, 2019
Influence of surface treatment on the fluorescence of composite resins subjected to in situ bleachingLourdes M G García, Ana Paula T de Godoi, Osvaldo A Serra, et al.
The Journal of Trauma and Acute Care Surgery|April 11, 2023
Burn excision within 48 hours portends better outcomes than standard management: A nationwide analysisWalter A Ramsey, Christopher F O'Neil, Andres M Corona, et al.
The Lancet. Oncology|May 1, 2020
Abemaciclib plus trastuzumab with or without fulvestrant versus trastuzumab plus standard-of-care chemotherapy in women with hormone receptor-positive, HER2-positive advanced breast cancer (monarcHER): a randomised, open-label, phase 2 trialSara M Tolaney, Andrew M Wardley, Stefania Zambelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2011
Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancerMartin R Stockler, Vernon J Harvey, Prudence A Francis, et al.
Pageof 13